| 000 | 01677 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513143744.0 | ||
| 264 | 0 | _c19980622 | |
| 008 | 199806s 0 0 eng d | ||
| 022 | _a0969-7128 | ||
| 024 | 7 |
_a10.1038/sj.gt.3300619 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSun, Y | |
| 245 | 0 | 0 |
_aVaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study. _h[electronic resource] |
| 260 |
_bGene therapy _cApr 1998 |
||
| 300 |
_a481-90 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBiolistics |
| 650 | 0 | 4 | _aCancer Vaccines |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypersensitivity, Delayed |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aInterleukin-10 _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-12 _xgenetics |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _ximmunology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xmetabolism |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aJurgovsky, K | |
| 700 | 1 | _aMöller, P | |
| 700 | 1 | _aAlijagic, S | |
| 700 | 1 | _aDorbic, T | |
| 700 | 1 | _aGeorgieva, J | |
| 700 | 1 | _aWittig, B | |
| 700 | 1 | _aSchadendorf, D | |
| 773 | 0 |
_tGene therapy _gvol. 5 _gno. 4 _gp. 481-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.gt.3300619 _zAvailable from publisher's website |
| 999 |
_c9581127 _d9581127 |
||